Current articles:

The methodology for cost analysis in pharmacoeconomic researches.
Yagudina R. I., Kulikov A. Yu., Komarov I.
Pharmacoeconomics. 2011; 3: 3-6

Distribution of costs of pharmacotherapy during the inpatient management of acute obstructive bronchitis in children, making use of pharmacoeconomic studies.
Zhukova O. V., Kononova S. V., Konyshkina T. M.
Pharmacoeconomics. 2011; 3: 7-9

Application of ATC/DDD method for calculation of projected drug requirements within the program of provision of vitally important medicines.
Komissinskaya I. G., Stepchenko A. A., Ryzhova E. V.
Pharmacoeconomics. 2011; 3: 10-13

Pharmacoeconomic modeling of medicinal drug use during treatment of HIV infection.
Yagudina R.I., Kulikov A.Yu., Zinchuk I.Yu.
Pharmacoeconomics. 2011; 3: 14-18

Pharmacoeconomic evaluation of medicinal treatment during radical prostatectomy.
Katibov M. I., Apolikhin O. I., Perepanova T. S.
Pharmacoeconomics. 2011; 3: 19-22

Effectiveness of expenditure for bendamustine treatment of indolent Non-Hodgkin lymphomas.
Rudakova A. V.
Pharmacoeconomics. 2011; 3: 23-28

Effectiveness of expenditure for bendamustine treatment of chronic lymphocytic leukemia.
Rudakova A. V.
Pharmacoeconomics. 2011; 3: 29-33

Prospects of development of the market of biotechnological medical products in Russia.
Borisov D. A.¹, Protsenko M. V.¹, Pechenkin A. V.²
Pharmacoeconomics. 2011; 3: 34-39

Theoretical basis of pharmacoeconomics analysis: budget impact analysis.
Yagudina R. I., Kulikov A.Yu.
Pharmacoeconomics. 2011; 2: 9-12

The State registry of medicinal products for medical use — retrospective analysis, current state, and improvement of requirements (analytical review of legislation).
Mironov A. N., Digtyar A. V., Sakaeva I. V,. Koshechkin K. A.
Pharmacoeconomics. 2011; 2: 13-17